Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes

• Published in: Schizophrenia research Vol. 226; pp. 138 - 146
• Main Authors: Cui, Huiru, Giuliano, Anthony J., Zhang, Tianhong, Xu, Lihua, Wei, Yanyan, Tang, Yingying, Qian, Zhenying, Stone, Lena M., Li, Huijun, Whitfield-Gabrieli, Susan, Niznikiewicz, Margaret, Keshavan, Matcheri S., Shenton, Martha E., Wang, Jijun, Stone, William S.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.12.2020
• Subjects: Clinical high risk; Conversion; Neurocognition; Prodromal; Psychiatric/Mental Health; Psychosis; Schizophrenia; Psychosis; Schizophrenia; Clinical high risk; Neurocognition; Conversion; Prodromal
• ISSN: 0920-9964; 1573-2509; 1573-2509
• DOI: 10.1016/j.schres.2020.06.018

1) to assess generalizability of neurocognitive deficits reported in previous Western clinical high-risk (CHR) for psychosis studies in a prodromal program in Shanghai, China; and 2) to investigate neurocognition in CHR subjects in relation to a broader range of clinical outcomes (e.g. remission) th...